Review



cd56 cd4  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Miltenyi Biotec cd56 cd4
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Cd56 Cd4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd56 cd4/product/Miltenyi Biotec
    Average 99 stars, based on 30 article reviews
    cd56 cd4 - by Bioz Stars, 2026-03
    99/100 stars

    Images

    1) Product Images from "NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control"

    Article Title: NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control

    Journal: bioRxiv

    doi: 10.1101/2025.11.19.688897

    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR (CD4-MBL-CD8TM-4-1BB-CD3z), CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, CD56+, and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Figure Legend Snippet: A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR (CD4-MBL-CD8TM-4-1BB-CD3z), CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, CD56+, and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).

    Techniques Used: Expressing, Knock-Out, Flow Cytometry, Reverse Transcription Polymerase Chain Reaction, Control, Enzyme-linked Immunosorbent Assay, Cell Culture, Lysis, Cytotoxicity Assay, Standard Deviation

    NK (CD56+) cells in CAR (blue), control (black), or PBS (red) treated groups from A) Peripheral Blood, B) Lymph node (at necropsies), and C) Spleen (at necropsies). CAR+CXCR5+ NK cells over time in D) Peripheral Blood, E) Lymph node (at necropsies), and F) Spleen (at necropsies). Flow was pre-gated on Lymphocytes, Singlets, Live Cells, human CD45+, mouse CD45-, CD3+, and then through CD56+ MBL+ CXCR5+ (see Fig. S4 for gating strategy). Median viral loads (green), NK cell levels (orange), post-treatment in G) controllers or H) non-controllers. I) Median human hematopoietic cell counts (CD45+)/ ul blood of controllers (gray) or non-controllers (pink).
    Figure Legend Snippet: NK (CD56+) cells in CAR (blue), control (black), or PBS (red) treated groups from A) Peripheral Blood, B) Lymph node (at necropsies), and C) Spleen (at necropsies). CAR+CXCR5+ NK cells over time in D) Peripheral Blood, E) Lymph node (at necropsies), and F) Spleen (at necropsies). Flow was pre-gated on Lymphocytes, Singlets, Live Cells, human CD45+, mouse CD45-, CD3+, and then through CD56+ MBL+ CXCR5+ (see Fig. S4 for gating strategy). Median viral loads (green), NK cell levels (orange), post-treatment in G) controllers or H) non-controllers. I) Median human hematopoietic cell counts (CD45+)/ ul blood of controllers (gray) or non-controllers (pink).

    Techniques Used: Control

    CD4:CD8 ratios over time in A) CAR NK-treated animals (blue), B) control NK-treated animals (black), and C) PBS-treated animals (red). CD4:CD8 ratios in CAR (blue), control NK (black), and PBS (red) treated groups at D) -6 DPT, E) 6 DPT, F) 14 DPT, G) 28 DPT, H) 42 DPT, and I) 56 DPT. Lines represent median values. CD4:CD8 ratios were determined by flow cytometry and pre-gated on Lymphocytes, Singlets, Live Cells, Human CD45+, Mouse CD45-, CD3+ (see gating strategy in Fig. S4 ).
    Figure Legend Snippet: CD4:CD8 ratios over time in A) CAR NK-treated animals (blue), B) control NK-treated animals (black), and C) PBS-treated animals (red). CD4:CD8 ratios in CAR (blue), control NK (black), and PBS (red) treated groups at D) -6 DPT, E) 6 DPT, F) 14 DPT, G) 28 DPT, H) 42 DPT, and I) 56 DPT. Lines represent median values. CD4:CD8 ratios were determined by flow cytometry and pre-gated on Lymphocytes, Singlets, Live Cells, Human CD45+, Mouse CD45-, CD3+ (see gating strategy in Fig. S4 ).

    Techniques Used: Control, Flow Cytometry



    Similar Products

    99
    Miltenyi Biotec cd56 cd4
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Cd56 Cd4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd56 cd4/product/Miltenyi Biotec
    Average 99 stars, based on 1 article reviews
    cd56 cd4 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec cd4 cd56 cd45ra t cell fraction
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Cd4 Cd56 Cd45ra T Cell Fraction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 cd56 cd45ra t cell fraction/product/Miltenyi Biotec
    Average 99 stars, based on 1 article reviews
    cd4 cd56 cd45ra t cell fraction - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec antigen cd16 cd56 cd3 cd4 cd8 cd19 cd45 fluorochrome fitc pe vioblue percp vio700 pevio770 apc viogreen
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Antigen Cd16 Cd56 Cd3 Cd4 Cd8 Cd19 Cd45 Fluorochrome Fitc Pe Vioblue Percp Vio700 Pevio770 Apc Viogreen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antigen cd16 cd56 cd3 cd4 cd8 cd19 cd45 fluorochrome fitc pe vioblue percp vio700 pevio770 apc viogreen/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    antigen cd16 cd56 cd3 cd4 cd8 cd19 cd45 fluorochrome fitc pe vioblue percp vio700 pevio770 apc viogreen - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec cd3 tcrαβ cd4 cd8 cd56 dnt
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Cd3 Tcrαβ Cd4 Cd8 Cd56 Dnt, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd3 tcrαβ cd4 cd8 cd56 dnt/product/Miltenyi Biotec
    Average 99 stars, based on 1 article reviews
    cd3 tcrαβ cd4 cd8 cd56 dnt - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Becton Dickinson monoclonal antibodies cd3, cd16, cd56, cd4, cd8, cd19, bd multitest 6-color tbnk
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Monoclonal Antibodies Cd3, Cd16, Cd56, Cd4, Cd8, Cd19, Bd Multitest 6 Color Tbnk, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal antibodies cd3, cd16, cd56, cd4, cd8, cd19, bd multitest 6-color tbnk/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    monoclonal antibodies cd3, cd16, cd56, cd4, cd8, cd19, bd multitest 6-color tbnk - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc anti cd3 fitc/cd56 pe/γδ pc7, cd8 fitc/cd4 pe/cd28 pc7, and igg1 fitc/pe/pc7 from beckman coulter in
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Anti Cd3 Fitc/Cd56 Pe/γδ Pc7, Cd8 Fitc/Cd4 Pe/Cd28 Pc7, And Igg1 Fitc/Pe/Pc7 From Beckman Coulter In, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 fitc/cd56 pe/γδ pc7, cd8 fitc/cd4 pe/cd28 pc7, and igg1 fitc/pe/pc7 from beckman coulter in/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    anti cd3 fitc/cd56 pe/γδ pc7, cd8 fitc/cd4 pe/cd28 pc7, and igg1 fitc/pe/pc7 from beckman coulter in - by Bioz Stars, 2026-03
    86/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc cd3
    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR <t>(CD4-MBL-CD8TM-4-1BB-CD3z),</t> CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, <t>CD56+,</t> and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).
    Cd3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd3/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    cd3 - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc cd56 cd4 cd14 nk cells
    ( A ) Flow diagram summarizing the participant recruitment in this study. See “Methods” and Dataset for details of inclusion criteria and demographic information of participants included, respectively. ( B ) Representative results of fluorescence-activated cell sorting (FACS)-based analyses for frequencies of immune cell subsets in peripheral blood of individuals from HC, LTBI, and ATB groups. Each immune cell subsets were characterized using standard cell subset definitions. NK cell gating: FSC, SSC, CD3 – , CD19 – , <t>CD56</t> bright/dim ; T cell gating: FSC, SSC, CD3 + , CD19 – , CD56 – ; B cell gating: FSC, SSC, CD3 – , CD19 + , CD56 – ; monocyte gating: FSC, SSC, CD3 – , CD19 – , <t>CD14</t> + . ( C ) The number of immune cell subsets in peripheral blood of individuals ( n ) from HC, LTBI, and ATB groups. Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc test ( C ). .
    Cd56 Cd4 Cd14 Nk Cells, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd56 cd4 cd14 nk cells/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    cd56 cd4 cd14 nk cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    90
    Becton Dickinson human lineage cocktail 4 (cd2, cd3, cd4, cd7, cd8, cd10, cd11b, cd14, cd19, cd20, cd56, cd235a)
    ( A ) Flow diagram summarizing the participant recruitment in this study. See “Methods” and Dataset for details of inclusion criteria and demographic information of participants included, respectively. ( B ) Representative results of fluorescence-activated cell sorting (FACS)-based analyses for frequencies of immune cell subsets in peripheral blood of individuals from HC, LTBI, and ATB groups. Each immune cell subsets were characterized using standard cell subset definitions. NK cell gating: FSC, SSC, CD3 – , CD19 – , <t>CD56</t> bright/dim ; T cell gating: FSC, SSC, CD3 + , CD19 – , CD56 – ; B cell gating: FSC, SSC, CD3 – , CD19 + , CD56 – ; monocyte gating: FSC, SSC, CD3 – , CD19 – , <t>CD14</t> + . ( C ) The number of immune cell subsets in peripheral blood of individuals ( n ) from HC, LTBI, and ATB groups. Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc test ( C ). .
    Human Lineage Cocktail 4 (Cd2, Cd3, Cd4, Cd7, Cd8, Cd10, Cd11b, Cd14, Cd19, Cd20, Cd56, Cd235a), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lineage cocktail 4 (cd2, cd3, cd4, cd7, cd8, cd10, cd11b, cd14, cd19, cd20, cd56, cd235a)/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    human lineage cocktail 4 (cd2, cd3, cd4, cd7, cd8, cd10, cd11b, cd14, cd19, cd20, cd56, cd235a) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR (CD4-MBL-CD8TM-4-1BB-CD3z), CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, CD56+, and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).

    Journal: bioRxiv

    Article Title: NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control

    doi: 10.1101/2025.11.19.688897

    Figure Lengend Snippet: A) Schematic figure showing the overview of NK cell production and the overview of the mouse study timeline. Red circles on the timeline indicate blood collection, black dots indicate scheduled necropsies. Schematic of transgene design: MND promoter, CAR (CD4-MBL-CD8TM-4-1BB-CD3z), CXCR5, IL-15, the BgH PolyA tail, with separation mediated by P2A and T2A sites, and inverted terminal repeats (ITRs). Schematic showing expression of all transgene components as well as base editor-mediated knock out of PD-1 on the NK cell surface. Figure made using Biorender.com. B) Expression of CAR (MBL) and CXCR5 molecules was confirmed in the cell product using flow cytometry. Cells were pre-gated sequentially on lymphocytes, singlets, live cells, CD56+, and CD3-. C) PD-1 knockout was detected at the RNA level by RT-PCR, CAR NK (blue) relative to control NK cells (black). D) IL-15 expression in CAR NK (blue) and control NK (black) cells via IL-15 ELISA of cell culture supernatant. E) CAR (blue) and control (black) cell proliferation over one week post-thaw. F) The specific lysis of HIV Envelope P815s by CAR (blue) or control (black) NK cells via DELFIA cytotoxicity assay. 5:1, 10:1, and 20:1 E:T ratios were tested. All assays were performed in duplicate or triplicate. Data are represented as mean + standard deviation (error bars).

    Article Snippet: After a 2-day recovery, CAR NK cells were sorted on CD56+ CD4+ using the MACSQuant Tyto Cell Sorter (Miltenyi Biotec) and expanded for an additional 7 days following the procedure described above.

    Techniques: Expressing, Knock-Out, Flow Cytometry, Reverse Transcription Polymerase Chain Reaction, Control, Enzyme-linked Immunosorbent Assay, Cell Culture, Lysis, Cytotoxicity Assay, Standard Deviation

    NK (CD56+) cells in CAR (blue), control (black), or PBS (red) treated groups from A) Peripheral Blood, B) Lymph node (at necropsies), and C) Spleen (at necropsies). CAR+CXCR5+ NK cells over time in D) Peripheral Blood, E) Lymph node (at necropsies), and F) Spleen (at necropsies). Flow was pre-gated on Lymphocytes, Singlets, Live Cells, human CD45+, mouse CD45-, CD3+, and then through CD56+ MBL+ CXCR5+ (see Fig. S4 for gating strategy). Median viral loads (green), NK cell levels (orange), post-treatment in G) controllers or H) non-controllers. I) Median human hematopoietic cell counts (CD45+)/ ul blood of controllers (gray) or non-controllers (pink).

    Journal: bioRxiv

    Article Title: NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control

    doi: 10.1101/2025.11.19.688897

    Figure Lengend Snippet: NK (CD56+) cells in CAR (blue), control (black), or PBS (red) treated groups from A) Peripheral Blood, B) Lymph node (at necropsies), and C) Spleen (at necropsies). CAR+CXCR5+ NK cells over time in D) Peripheral Blood, E) Lymph node (at necropsies), and F) Spleen (at necropsies). Flow was pre-gated on Lymphocytes, Singlets, Live Cells, human CD45+, mouse CD45-, CD3+, and then through CD56+ MBL+ CXCR5+ (see Fig. S4 for gating strategy). Median viral loads (green), NK cell levels (orange), post-treatment in G) controllers or H) non-controllers. I) Median human hematopoietic cell counts (CD45+)/ ul blood of controllers (gray) or non-controllers (pink).

    Article Snippet: After a 2-day recovery, CAR NK cells were sorted on CD56+ CD4+ using the MACSQuant Tyto Cell Sorter (Miltenyi Biotec) and expanded for an additional 7 days following the procedure described above.

    Techniques: Control

    CD4:CD8 ratios over time in A) CAR NK-treated animals (blue), B) control NK-treated animals (black), and C) PBS-treated animals (red). CD4:CD8 ratios in CAR (blue), control NK (black), and PBS (red) treated groups at D) -6 DPT, E) 6 DPT, F) 14 DPT, G) 28 DPT, H) 42 DPT, and I) 56 DPT. Lines represent median values. CD4:CD8 ratios were determined by flow cytometry and pre-gated on Lymphocytes, Singlets, Live Cells, Human CD45+, Mouse CD45-, CD3+ (see gating strategy in Fig. S4 ).

    Journal: bioRxiv

    Article Title: NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control

    doi: 10.1101/2025.11.19.688897

    Figure Lengend Snippet: CD4:CD8 ratios over time in A) CAR NK-treated animals (blue), B) control NK-treated animals (black), and C) PBS-treated animals (red). CD4:CD8 ratios in CAR (blue), control NK (black), and PBS (red) treated groups at D) -6 DPT, E) 6 DPT, F) 14 DPT, G) 28 DPT, H) 42 DPT, and I) 56 DPT. Lines represent median values. CD4:CD8 ratios were determined by flow cytometry and pre-gated on Lymphocytes, Singlets, Live Cells, Human CD45+, Mouse CD45-, CD3+ (see gating strategy in Fig. S4 ).

    Article Snippet: After a 2-day recovery, CAR NK cells were sorted on CD56+ CD4+ using the MACSQuant Tyto Cell Sorter (Miltenyi Biotec) and expanded for an additional 7 days following the procedure described above.

    Techniques: Control, Flow Cytometry

    ( A ) Flow diagram summarizing the participant recruitment in this study. See “Methods” and Dataset for details of inclusion criteria and demographic information of participants included, respectively. ( B ) Representative results of fluorescence-activated cell sorting (FACS)-based analyses for frequencies of immune cell subsets in peripheral blood of individuals from HC, LTBI, and ATB groups. Each immune cell subsets were characterized using standard cell subset definitions. NK cell gating: FSC, SSC, CD3 – , CD19 – , CD56 bright/dim ; T cell gating: FSC, SSC, CD3 + , CD19 – , CD56 – ; B cell gating: FSC, SSC, CD3 – , CD19 + , CD56 – ; monocyte gating: FSC, SSC, CD3 – , CD19 – , CD14 + . ( C ) The number of immune cell subsets in peripheral blood of individuals ( n ) from HC, LTBI, and ATB groups. Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc test ( C ). .

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: ( A ) Flow diagram summarizing the participant recruitment in this study. See “Methods” and Dataset for details of inclusion criteria and demographic information of participants included, respectively. ( B ) Representative results of fluorescence-activated cell sorting (FACS)-based analyses for frequencies of immune cell subsets in peripheral blood of individuals from HC, LTBI, and ATB groups. Each immune cell subsets were characterized using standard cell subset definitions. NK cell gating: FSC, SSC, CD3 – , CD19 – , CD56 bright/dim ; T cell gating: FSC, SSC, CD3 + , CD19 – , CD56 – ; B cell gating: FSC, SSC, CD3 – , CD19 + , CD56 – ; monocyte gating: FSC, SSC, CD3 – , CD19 – , CD14 + . ( C ) The number of immune cell subsets in peripheral blood of individuals ( n ) from HC, LTBI, and ATB groups. Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc test ( C ). .

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Fluorescence, FACS

    ( A ) Correlation analysis of expression between LILRB1 and other markers including GZMB, PRF1, IFN-γ, and TNF-α based on CyTOF single-cell data ( n = 35,000 cells). ( B – D ) Percentages of CD107a + ( B ), IFN-γ + ( C ), or TNF-α + ( D ) cells within total NK cells. ( E , F ) Supernatant levels of GZMB ( E ) and PRF1 ( F ) in MDM-NK cell co-cultures. ( G ) Percentages of apoptotic cells within total NK cells. ( H ) Mtb survival in MDM-NK cell co-cultures. For ( B – H ), HC donor-derived NK cells with overexpression of MSCV or MSCV-LILRB1 were co-cultured with or without Mtb-infected MDMs (Mtb-Mφ) for 24 h. ( I ) Histological and immunofluorescence analysis of human lung sections containing non-necrotic or necrotic TB granulomas or healthy control tissues adjacent to granulomatous lesions. Left, representative images (scale bars, 200 μm) for hematoxylin and eosin (H&E) staining. Right, representative images (scale bars, 10 μm) for cells stained with antibodies against LILRB1 (blue), CD56 (green), and CD69 or CD103 (red). Nuclei were stained with DAPI (gray). ( J , K ) Quantitation of LILRB1 expression in CD56 + CD69 + or CD56 + CD69 – NK cells ( J ) and CD56 + CD103 + or CD56 + CD103 – NK cells ( K ). For ( I – K ), lung sections from 5 ATB patients were examined. Data are mean ± SEM ( n = 5 donors per group) in ( B – H , J , K ). Statistical significance was determined using two-way ANOVA ( B – G , J , K ) or one-way ANOVA ( H ) with Tukey’s post-hoc test. Results are representative of three independent experiments. .

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: ( A ) Correlation analysis of expression between LILRB1 and other markers including GZMB, PRF1, IFN-γ, and TNF-α based on CyTOF single-cell data ( n = 35,000 cells). ( B – D ) Percentages of CD107a + ( B ), IFN-γ + ( C ), or TNF-α + ( D ) cells within total NK cells. ( E , F ) Supernatant levels of GZMB ( E ) and PRF1 ( F ) in MDM-NK cell co-cultures. ( G ) Percentages of apoptotic cells within total NK cells. ( H ) Mtb survival in MDM-NK cell co-cultures. For ( B – H ), HC donor-derived NK cells with overexpression of MSCV or MSCV-LILRB1 were co-cultured with or without Mtb-infected MDMs (Mtb-Mφ) for 24 h. ( I ) Histological and immunofluorescence analysis of human lung sections containing non-necrotic or necrotic TB granulomas or healthy control tissues adjacent to granulomatous lesions. Left, representative images (scale bars, 200 μm) for hematoxylin and eosin (H&E) staining. Right, representative images (scale bars, 10 μm) for cells stained with antibodies against LILRB1 (blue), CD56 (green), and CD69 or CD103 (red). Nuclei were stained with DAPI (gray). ( J , K ) Quantitation of LILRB1 expression in CD56 + CD69 + or CD56 + CD69 – NK cells ( J ) and CD56 + CD103 + or CD56 + CD103 – NK cells ( K ). For ( I – K ), lung sections from 5 ATB patients were examined. Data are mean ± SEM ( n = 5 donors per group) in ( B – H , J , K ). Statistical significance was determined using two-way ANOVA ( B – G , J , K ) or one-way ANOVA ( H ) with Tukey’s post-hoc test. Results are representative of three independent experiments. .

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Expressing, Derivative Assay, Over Expression, Cell Culture, Infection, Immunofluorescence, Control, Staining, Quantitation Assay

    ( A ) Representative results of FACS-based analysis for percentages of CD3 – CD56 + CD4 + CD14 + cells within total CD3 – CD56 + NK cells from the peripheral blood of individuals in HC, LTBI, or ATB groups. ( B ) Percentages of CD3 – CD56 + CD4 + CD14 + cells within total CD3 – CD56 + NK cells in the peripheral blood of individuals ( n ) from HC, LTBI, or ATB groups. Box-whisker plot indicates the interquartile range (box), the median value (line within the box), and the maximum and minimum value (whiskers). ( C ) The number of CD3 – CD56 + CD4 + CD14 + cells in the peripheral blood of individuals ( n ) from HC, LTBI, or ATB groups. ( D , E ) Percentages of IFN-γ + ( D ) and TNF-α + ( E ) cells in total CD3 – CD56 + CD4 + CD14 + cells. CD3 – CD56 + CD4 + CD14 + cells were co-cultured with or without Mtb-Mφ at a ratio of 3:1 for 24 h in the presence of anti-LILRB1 (GHI/75) mAb or IgG control. Data are mean ± SEM ( n = 6 donors per group) in ( D , E ). Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc test for ( B – E ). Results are representative of three independent experiments. .

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: ( A ) Representative results of FACS-based analysis for percentages of CD3 – CD56 + CD4 + CD14 + cells within total CD3 – CD56 + NK cells from the peripheral blood of individuals in HC, LTBI, or ATB groups. ( B ) Percentages of CD3 – CD56 + CD4 + CD14 + cells within total CD3 – CD56 + NK cells in the peripheral blood of individuals ( n ) from HC, LTBI, or ATB groups. Box-whisker plot indicates the interquartile range (box), the median value (line within the box), and the maximum and minimum value (whiskers). ( C ) The number of CD3 – CD56 + CD4 + CD14 + cells in the peripheral blood of individuals ( n ) from HC, LTBI, or ATB groups. ( D , E ) Percentages of IFN-γ + ( D ) and TNF-α + ( E ) cells in total CD3 – CD56 + CD4 + CD14 + cells. CD3 – CD56 + CD4 + CD14 + cells were co-cultured with or without Mtb-Mφ at a ratio of 3:1 for 24 h in the presence of anti-LILRB1 (GHI/75) mAb or IgG control. Data are mean ± SEM ( n = 6 donors per group) in ( D , E ). Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc test for ( B – E ). Results are representative of three independent experiments. .

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Whisker Assay, Cell Culture, Control

    ( A , B ) Representative images (left) and quantitation (right) for immunofluorescence examining the granule polarization ( A ) and cytotoxic activity ( B ) of CD3 – CD56 + CD4 + CD14 + cells (effector cells) towards Mtb-infected MDMs (Mtb-Mφ). CD3 – CD56 + CD4 + CD14 + cells were co-cultured with Mtb-Mφ at a ratio of 3:1 for 24 h in the presence of anti-LILRB1 (GHI/75) mAb or IgG control. Bacteria were stained with Alexa Fluor 488 succinimidyl ester (green) before infection. CD3 – CD56 + CD4 + CD14 + cells were prestained with Hoechst (blue) for visualization, and were labeled with LysoTracker (red; white arrows) to monitor lytic granule polarization towards target cells, a characteristic of NK cells during degranulation. MDM lysis was determined by uptake of DRAQ7 (red; black arrows). Scale bars, 10 μm. Approximately 100 cells were examined. N.D., not detectable. ( C ) Time-lapse analysis (left) and quantitation (right) of calcein release from Mtb-Mφ. CD3 – CD56 + CD4 + CD14 + cells were co-cultured with Mtb-Mφ as in ( A , B ) for 12 h and were then monitored for 2 h. Bacteria were stained with Alexa Fluor 594 succinimidyl ester (red) before infection. MDMs were preloaded with calcein (green), an indicator of cell viability that was released from dead cells lysed by effector cells (arrows). Scale bars, 10 μm. See also Movies and . ( D – G ) Percentages of CD107a + ( D ), GZMB + ( E ), PRF1 + ( F ), and apoptotic ( G ) cells in total CD3 – CD56 + CD4 + CD14 + cells. CD3 – CD56 + CD4 + CD14 + cells were co-cultured with or without Mtb-Mφ at a ratio of 3:1 for 24 h in the presence of anti-LILRB1 (GHI/75) mAb or IgG control. ( H ) Mtb survival in MDM-effector cell co-cultures. MDMs were infected with Mtb, followed by co-culture with or without CD3 – CD56 + CD4 + CD14 + cells as in ( D – G ) for 24 h. Data are mean ± SEM [ n = 5 donors per group in ( A – C ) and n = 6 donors per group in ( D – H )]. Statistical significance was determined using two-way ANOVA ( A – C ) or one-way ANOVA ( D – H ) with Tukey’s post-hoc test. Results are representative of three independent experiments. .

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: ( A , B ) Representative images (left) and quantitation (right) for immunofluorescence examining the granule polarization ( A ) and cytotoxic activity ( B ) of CD3 – CD56 + CD4 + CD14 + cells (effector cells) towards Mtb-infected MDMs (Mtb-Mφ). CD3 – CD56 + CD4 + CD14 + cells were co-cultured with Mtb-Mφ at a ratio of 3:1 for 24 h in the presence of anti-LILRB1 (GHI/75) mAb or IgG control. Bacteria were stained with Alexa Fluor 488 succinimidyl ester (green) before infection. CD3 – CD56 + CD4 + CD14 + cells were prestained with Hoechst (blue) for visualization, and were labeled with LysoTracker (red; white arrows) to monitor lytic granule polarization towards target cells, a characteristic of NK cells during degranulation. MDM lysis was determined by uptake of DRAQ7 (red; black arrows). Scale bars, 10 μm. Approximately 100 cells were examined. N.D., not detectable. ( C ) Time-lapse analysis (left) and quantitation (right) of calcein release from Mtb-Mφ. CD3 – CD56 + CD4 + CD14 + cells were co-cultured with Mtb-Mφ as in ( A , B ) for 12 h and were then monitored for 2 h. Bacteria were stained with Alexa Fluor 594 succinimidyl ester (red) before infection. MDMs were preloaded with calcein (green), an indicator of cell viability that was released from dead cells lysed by effector cells (arrows). Scale bars, 10 μm. See also Movies and . ( D – G ) Percentages of CD107a + ( D ), GZMB + ( E ), PRF1 + ( F ), and apoptotic ( G ) cells in total CD3 – CD56 + CD4 + CD14 + cells. CD3 – CD56 + CD4 + CD14 + cells were co-cultured with or without Mtb-Mφ at a ratio of 3:1 for 24 h in the presence of anti-LILRB1 (GHI/75) mAb or IgG control. ( H ) Mtb survival in MDM-effector cell co-cultures. MDMs were infected with Mtb, followed by co-culture with or without CD3 – CD56 + CD4 + CD14 + cells as in ( D – G ) for 24 h. Data are mean ± SEM [ n = 5 donors per group in ( A – C ) and n = 6 donors per group in ( D – H )]. Statistical significance was determined using two-way ANOVA ( A – C ) or one-way ANOVA ( D – H ) with Tukey’s post-hoc test. Results are representative of three independent experiments. .

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Quantitation Assay, Immunofluorescence, Activity Assay, Infection, Cell Culture, Control, Bacteria, Staining, Labeling, Lysis, Co-Culture Assay

    ( A ) Schematic representation of the experimental design. PBMCs from individuals in HC, LTBI, or ATB group were transplanted to NCG mice. Two weeks later, mice were infected with Mtb by aerosol (~100 CFUs) for 4 weeks with treatment of PBS (as control), IgG control, or anti-LILRB1 blocking pAb every 3 days, together with treatment of corn oil (as control) or SCH772984 every 2 days. ( B ) Representative images (upper) and quantitation (lower) for H&E staining, acid-fast staining, and immunostaining of lung sections. Scale bars, 1 mm, 10 μm, and 10 μm, respectively. For immunostaining, NK cells were stained with anti-human CD56 antibody (red), apoptotic cells were stained with TUNEL (green), and nuclei were stained with DAPI (blue). Black arrows indicate granuloma-like inflammatory lesions. Black arrowheads indicate Mtb. White arrowheads indicate TUNEL-positive NK cells. ( C , D ) Enzyme-linked immunosorbent assay (ELISA) of GZMB ( C ) or PRF1 ( D ) in the lungs. ( E , F ) Bacterial CFUs in the lungs ( E ) or spleens ( F ). For ( B – F ), each group (HC, LTBI, or ATB) includes 5 donors, and each donor’s PBMCs were transplanted to four mice, which were subjected to four different treatments as indicated (PBS, IgG control, anti-LILRB1 blocking pAb, and anti-LILRB1 blocking pAb along with SCH772984, respectively). Data are mean ± SEM ( n = 5 mice per treatment group). Statistical significance was determined using two-way ANOVA with Tukey’s post-hoc test ( B – F ). Results are representative of two independent experiments. .

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: ( A ) Schematic representation of the experimental design. PBMCs from individuals in HC, LTBI, or ATB group were transplanted to NCG mice. Two weeks later, mice were infected with Mtb by aerosol (~100 CFUs) for 4 weeks with treatment of PBS (as control), IgG control, or anti-LILRB1 blocking pAb every 3 days, together with treatment of corn oil (as control) or SCH772984 every 2 days. ( B ) Representative images (upper) and quantitation (lower) for H&E staining, acid-fast staining, and immunostaining of lung sections. Scale bars, 1 mm, 10 μm, and 10 μm, respectively. For immunostaining, NK cells were stained with anti-human CD56 antibody (red), apoptotic cells were stained with TUNEL (green), and nuclei were stained with DAPI (blue). Black arrows indicate granuloma-like inflammatory lesions. Black arrowheads indicate Mtb. White arrowheads indicate TUNEL-positive NK cells. ( C , D ) Enzyme-linked immunosorbent assay (ELISA) of GZMB ( C ) or PRF1 ( D ) in the lungs. ( E , F ) Bacterial CFUs in the lungs ( E ) or spleens ( F ). For ( B – F ), each group (HC, LTBI, or ATB) includes 5 donors, and each donor’s PBMCs were transplanted to four mice, which were subjected to four different treatments as indicated (PBS, IgG control, anti-LILRB1 blocking pAb, and anti-LILRB1 blocking pAb along with SCH772984, respectively). Data are mean ± SEM ( n = 5 mice per treatment group). Statistical significance was determined using two-way ANOVA with Tukey’s post-hoc test ( B – F ). Results are representative of two independent experiments. .

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Infection, Aerosol, Control, Blocking Assay, Quantitation Assay, Staining, Immunostaining, TUNEL Assay, Enzyme-linked Immunosorbent Assay

    ( A ) Schematic representation of the experimental design. Control PBMCs or NK cell-depleted (ΔNK) PBMCs from ATB patients were transplanted to NCG mice. Two weeks later, mice were infected with Mtb by aerosol (~100 CFUs) for 4 weeks with treatment of IgG control or anti-LILRB1 blocking pAb every 3 days. ( B , C ) Representative images (left) and quantitation (right) for H&E staining ( B ) and immunostaining ( C ) of lung sections. Scale bars, 1 mm and 10 μm, respectively. For immunostaining, NK cells were stained with anti-human CD56 antibody (red), apoptotic cells were stained with TUNEL (green), and nuclei were stained with DAPI (blue). Black arrows indicate granuloma-like inflammatory lesions. White arrows indicate TUNEL-positive NK cells. ( D , E ) ELISA of GZMB ( D ) or PRF1 ( E ) in the lungs. ( F , G ) Bacterial CFUs in the lungs ( F ) or spleens ( G ). For ( B – G ), a total of 6 ATB donors were included for collecting PBMCs, and each donor’s PBMCs were divided into two treatment groups, of which one was subjected to NK cell deprivation (ΔNK PBMCs) and one was not (control PBMCs). Then, the control PBMCs or ΔNK PBMCs from each donor were transplanted to two mice, of which one was treated with anti-LILRB1 blocking pAb and one was treated with IgG control. Data are mean ± SEM ( n = 6 mice per treatment group). Statistical significance was determined using two-way ANOVA with Tukey’s post-hoc test ( B – G ). Results are representative of two independent experiments. .

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: ( A ) Schematic representation of the experimental design. Control PBMCs or NK cell-depleted (ΔNK) PBMCs from ATB patients were transplanted to NCG mice. Two weeks later, mice were infected with Mtb by aerosol (~100 CFUs) for 4 weeks with treatment of IgG control or anti-LILRB1 blocking pAb every 3 days. ( B , C ) Representative images (left) and quantitation (right) for H&E staining ( B ) and immunostaining ( C ) of lung sections. Scale bars, 1 mm and 10 μm, respectively. For immunostaining, NK cells were stained with anti-human CD56 antibody (red), apoptotic cells were stained with TUNEL (green), and nuclei were stained with DAPI (blue). Black arrows indicate granuloma-like inflammatory lesions. White arrows indicate TUNEL-positive NK cells. ( D , E ) ELISA of GZMB ( D ) or PRF1 ( E ) in the lungs. ( F , G ) Bacterial CFUs in the lungs ( F ) or spleens ( G ). For ( B – G ), a total of 6 ATB donors were included for collecting PBMCs, and each donor’s PBMCs were divided into two treatment groups, of which one was subjected to NK cell deprivation (ΔNK PBMCs) and one was not (control PBMCs). Then, the control PBMCs or ΔNK PBMCs from each donor were transplanted to two mice, of which one was treated with anti-LILRB1 blocking pAb and one was treated with IgG control. Data are mean ± SEM ( n = 6 mice per treatment group). Statistical significance was determined using two-way ANOVA with Tukey’s post-hoc test ( B – G ). Results are representative of two independent experiments. .

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Control, Infection, Aerosol, Blocking Assay, Quantitation Assay, Staining, Immunostaining, TUNEL Assay, Enzyme-linked Immunosorbent Assay

    Reagents and tools table

    Journal: EMBO Molecular Medicine

    Article Title: LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

    doi: 10.1038/s44321-024-00106-1

    Figure Lengend Snippet: Reagents and tools table

    Article Snippet: Before co-culture, CD3 – CD56 + CD4 + CD14 + NK cells were prestained with 1 μg/mL Hoechst 33342 (Cell signaling Technology, Cat# 4082) at 37 °C for 10 min for visualization.

    Techniques: Recombinant, Western Blot, Sequencing, Modification, Cell Isolation, Enzyme-linked Immunosorbent Assay, Isolation, Antibody Labeling, Transfection, Lysis, Protease Inhibitor, Blocking Assay, Software, Flow Cytometry, Cytometry